Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 03/01/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/26/25
End: 01/01/28
Due: 01/01/29
Phase: N/A
Priority: Normal
Start: 05/31/23
End: 02/29/24
Due: 02/28/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation | NCT06275555 | Xiaotong Hou | user2@example.com | None | 2024-08-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO | NCT06276010 | Xiaotong Hou | user2@example.com | None | 2024-03-01 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients | NCT06862700 | Xiaotong Hou | user2@example.com | None | 2025-02-26 | 2028-01-01 | 2029-01-01 | - | - | 2025-07-14 |
| A Pilot Study of Sivelestat Sodium to Shorten Mechanical Ventilation in Acute Aortic Dissection | NCT05874700 | Xiaotong Hou | user2@example.com | None | 2023-05-31 | 2024-02-29 | 2025-02-28 | - | - | 2025-07-14 |